Walgreens Boots Alliance Inc (WBA) : Howland Capital Management reduced its stake in Walgreens Boots Alliance Inc by 0.83% during the most recent quarter end. The investment management company now holds a total of 289,833 shares of Walgreens Boots Alliance Inc which is valued at $22,664,941 after selling 2,415 shares in Walgreens Boots Alliance Inc , the firm said in a disclosure report filed with the SEC on Oct 13, 2016.Walgreens Boots Alliance Inc makes up approximately 2.15% of Howland Capital Management’s portfolio.
Other Hedge Funds, Including , Premier Asset Managment reduced its stake in WBA by selling 10,400 shares or 5.99% in the most recent quarter. The Hedge Fund company now holds 163,150 shares of WBA which is valued at $12,758,330. Walgreens Boots Alliance Inc makes up approx 3.25% of Premier Asset Managment’s portfolio.Chicago Trust Co Na reduced its stake in WBA by selling 16,990 shares or 33.97% in the most recent quarter. The Hedge Fund company now holds 33,019 shares of WBA which is valued at $2,578,124. Walgreens Boots Alliance Inc makes up approx 1.19% of Chicago Trust Co Na’s portfolio.Carroll Financial Associates boosted its stake in WBA in the latest quarter, The investment management firm added 161 additional shares and now holds a total of 1,046 shares of Walgreens Boots Alliance Inc which is valued at $83,314. Walgreens Boots Alliance Inc makes up approx 0.01% of Carroll Financial Associates’s portfolio. Nadler Financial Group sold out all of its stake in WBA during the most recent quarter. The investment firm sold 28,609 shares of WBA which is valued $2,285,287.New England Research Management reduced its stake in WBA by selling 200 shares or 4.91% in the most recent quarter. The Hedge Fund company now holds 3,875 shares of WBA which is valued at $311,976. Walgreens Boots Alliance Inc makes up approx 0.26% of New England Research Management’s portfolio.
Walgreens Boots Alliance Inc closed down -1.57 points or -1.97% at $78.08 with 55,24,004 shares getting traded on Tuesday. Post opening the session at $79.45, the shares hit an intraday low of $77.7975 and an intraday high of $79.51 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 6, 2016. Analyst had a consensus of $1.14. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Company shares were Reiterated by Deutsche Bank on Aug 30, 2016 to “Buy”, Firm has raised the Price Target to $ 94 from a previous price target of $93 .
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.